The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
106186678 10618667 8 F 20160829 20141202 20160901 EXP PHHY2013CA065916 NOVARTIS 0.00 M Y 0.00000 20160901 MD CA CA

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
106186678 10618667 1 PS TASIGNA NILOTINIB 1 Oral 300 MG, BID Y 22068 300 MG CAPSULE BID
106186678 10618667 2 SS TASIGNA NILOTINIB 1 Oral 300 MG, BID Y 22068 300 MG CAPSULE BID
106186678 10618667 3 SS TASIGNA NILOTINIB 1 Oral 300 MG, QD (ALL AT ONCE IN THE MORNING) Y 22068 300 MG CAPSULE QD
106186678 10618667 4 SS TASIGNA NILOTINIB 1 Oral 300 MG, BID Y 22068 300 MG CAPSULE BID
106186678 10618667 5 SS TASIGNA NILOTINIB 1 Oral 300 MG, QD Y 22068 300 MG CAPSULE QD
106186678 10618667 6 C ALEVE NAPROXEN SODIUM 1 Unknown UNK UNK, PRN U 0
106186678 10618667 7 C ASA ASPIRIN 1 Unknown 81 MG, QD U 0 81 MG QD
106186678 10618667 8 C TYLENOL ACETAMINOPHEN 1 Unknown UNK UNK, PRN U 0
106186678 10618667 9 C HYDROCHLOROTHIAZIDE. HYDROCHLOROTHIAZIDE 1 Unknown UNK Y 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
106186678 10618667 1 Chronic myeloid leukaemia
106186678 10618667 6 Headache
106186678 10618667 7 Product used for unknown indication
106186678 10618667 8 Headache
106186678 10618667 9 Product used for unknown indication

Outcome of event

Event ID CASEID OUTC COD
106186678 10618667 OT
106186678 10618667 LT

Reactions reported

Event ID CASEID DRUG REC ACT PT
106186678 10618667 Abnormal dreams
106186678 10618667 Aortic dilatation
106186678 10618667 Back pain
106186678 10618667 Blood cholesterol increased
106186678 10618667 Blood pressure increased
106186678 10618667 Chest pain
106186678 10618667 Concomitant disease aggravated
106186678 10618667 Cough
106186678 10618667 Decreased appetite
106186678 10618667 Dizziness
106186678 10618667 Dysgeusia
106186678 10618667 Dyspnoea
106186678 10618667 Fatigue
106186678 10618667 Feeling abnormal
106186678 10618667 Gastrointestinal oedema
106186678 10618667 Hair growth abnormal
106186678 10618667 Headache
106186678 10618667 Hypoaesthesia
106186678 10618667 Hypotonia
106186678 10618667 Miliaria
106186678 10618667 Nasopharyngitis
106186678 10618667 Neck pain
106186678 10618667 Night sweats
106186678 10618667 Overweight
106186678 10618667 Photosensitivity reaction
106186678 10618667 Pigmentation disorder
106186678 10618667 Pleurisy
106186678 10618667 Pruritus
106186678 10618667 Pyrexia
106186678 10618667 Rash
106186678 10618667 Rhinorrhoea
106186678 10618667 Sleep disorder
106186678 10618667 Sneezing
106186678 10618667 Solar lentigo
106186678 10618667 Therapeutic response unexpected
106186678 10618667 Throat irritation
106186678 10618667 Weight decreased
106186678 10618667 White blood cell count decreased

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
106186678 10618667 1 20130506 0
106186678 10618667 2 20130615 0
106186678 10618667 9 20151005 0